Publications

Publications from OUS - Chronic Infections Research Group

249 publications found

Publications 2019

1. Arnesen TM, Brantsæter AB, Nøkleby H (2019)
   Bacille Calmette-Guérin vaccination of healthcare personnel: changing epidemiology calls for new recommendations in Norway
   Eur Respir J, 53 (1)
   DOI 10.1183/13993003.01123-2018, PubMed 30630851
2. Hoel IM, Jørstad MD, Marijani M, Ruhwald M, Mustafa T, Dyrhol-Riise AM (2019)
   IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting
   Sci Rep, 9 (1), 3871
   DOI 10.1038/s41598-019-40458-0, PubMed 30846768
3. Huik K, Soodla P, Pauskar M, Owen SM, Luo W, Murphy G, Jogeda EL, Kallas E, Rajasaar H, Avi R, Masciotra S, Lutsar I, Del Amo J, Meyer L, Bucher HC, Chene G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Cartier A et al. (2019)
   The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx
   PLoS One, 14 (5), e0217048
4. Jørstad MD, Dyrhol-Riise AM, Aßmus J, Marijani M, Sviland L, Mustafa T (2019)
   Evaluation of treatment response in extrapulmonary tuberculosis in a low-resource setting
   BMC Infect Dis, 19 (1), 426
   DOI 10.1186/s12879-019-4034-z, PubMed 31096926
5. Quist-Paulsen E, Kran AB, Lindland ES, Ellefsen K, Sandvik L, Dunlop O, Ormaasen V (2019)
   To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? Results from a prospective observational study
   BMC Infect Dis, 19 (1), 80
   DOI 10.1186/s12879-018-3570-2, PubMed 30669985
6. Steens A, Winje BA, White RA, Odsbu I, Brantsæter AB, Vestrheim DF (2019)
   Indirect Effects of Pneumococcal Childhood Vaccination in Individuals Treated With Immunosuppressive Drugs in Ambulatory Care: A Case-cohort Study
   Clin Infect Dis, 68 (8), 1367-1373
   DOI 10.1093/cid/ciy714, PubMed 30957160
7. Stiksrud B, Aass HCD, Lorvik KB, Ueland T, Trøseid M, Dyrhol-Riise AM (2019)
   Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery
   AIDS, 33 (7), 1117-1129
   DOI 10.1097/QAD.0000000000002173, PubMed 30789356
8. Storm-Larsen C, Stiksrud B, Eriksen C, Nowak P, Holm K, Thalme A, Dyrhol-Riise AM, Brix S, Hov JR, Trøseid M (2019)
   Microbial translocation revisited: targeting the endotoxic potential of gut microbes in HIV-infected individuals
   AIDS, 33 (4), 645-653
   DOI 10.1097/QAD.0000000000002087, PubMed 30531315
9. Tonby K, Mortensen R, Ruhwald M, Dyrhol-Riise AM, Jenum S (2019)
   KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment
   J Infect Dis, 220 (1), 174-176
   DOI 10.1093/infdis/jiz056, PubMed 30888024
10. Waehre T, Petterson FO (2019)
    HIV medicines on offer gives worse treatment options
    Tidsskr. Nor. Laegeforen., 139 (2), 121-122
11. Wæhre T, Pettersen FO (2019)
    Poorer treatment options due to HIV drug tenders
    Tidsskr Nor Laegeforen, 139 (2)
    DOI 10.4045/tidsskr.19.0016, PubMed 30698395

Publications 2018

1. Habtamu M, Abebe M, Aseffa A, Dyrhol-Riise AM, Spurkland A, Abrahamsen G (2018)
   In vitro analysis of antigen induced T cell-monocyte conjugates by imaging flow cytometry
   J Immunol Methods, 460, 93-100
   DOI 10.1016/j.jim.2018.06.014, PubMed 29981305
2. Henjum K, Quist-Paulsen E, Zetterberg H, Blennow K, Nilsson LNG, Watne LO (2018)
   CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau
   J Neuroinflammation, 15 (1), 304
   DOI 10.1186/s12974-018-1331-1, PubMed 30390679
3. Jenum S, Selvam S, Jesuraj N, Ritz C, Hesseling AC, Cardenas V, Lau E, Doherty TM, Grewal HMS, Vaz M (2018)
   Incidence of tuberculosis and the influence of surveillance strategy on tuberculosis case-finding and all-cause mortality: a cluster randomised trial in Indian neonates vaccinated with BCG
   BMJ Open Respir Res, 5 (1), e000304
   DOI 10.1136/bmjresp-2018-000304, PubMed 30397482
4. Jørstad MD, Marijani M, Dyrhol-Riise AM, Sviland L, Mustafa T (2018)
   MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar
   PLoS One, 13 (5), e0196723
   DOI 10.1371/journal.pone.0196723, PubMed 29742144
5. Lindland ES, Solheim AM, Andreassen S, Quist-Paulsen E, Eikeland R, Ljøstad U, Mygland Å, Elsais A, Nygaard GO, Lorentzen ÅR, Harbo HF, Beyer MK (2018)
   Imaging in Lyme neuroborreliosis
   Insights Imaging, 9 (5), 833-844
   DOI 10.1007/s13244-018-0646-x, PubMed 30187265
6. Mocroft A, Laut K, Reiss P, Gatell J, Ormaasen V, Cavassini M, Hadziosmanovic V, Mansinho K, Pradier C, Vasylyev M, Mitsura V, Vandekerckhove L, Ostergaard L, Clarke A, Degen O, Mulcahy F, Castagna A, Sthoeger Z, Flamholc L, Sedláček D, Mozer-Lisewska I, Lundgren JD, EuroSIDA Study (2018)
   Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?
   AIDS, 32 (2), 205-215
   DOI 10.1097/QAD.0000000000001684, PubMed 29112060
7. Myhrvold IK, Cremaschi A, Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS (2018)
   Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia
   Oncotarget, 9 (10), 9273-9284
   DOI 10.18632/oncotarget.23949, PubMed 29507689
8. Naess-Andresen K, Sorsvang L, Berntzen LS, Waehre T (2018)
   Pregnant HIV positive must be followed closely
   Tidsskr. Nor. Laegeforen., 138 (11), 998-999
9. Orlien SMS, Ismael NY, Ahmed TA, Berhe N, Lauritzen T, Roald B, Goldin RD, Stene-Johansen K, Dyrhol-Riise AM, Gundersen SG, Morgan MY, Johannessen A (2018)
   Unexplained chronic liver disease in Ethiopia: a cross-sectional study
   BMC Gastroenterol, 18 (1), 27
   DOI 10.1186/s12876-018-0755-5, PubMed 29439653
10. Pelchen-Matthews A, Ryom L, Borges ÁH, Edwards S, Duvivier C, Stephan C, Sambatakou H, Maciejewska K, Portu JJ, Weber J, Degen O, Calmy A, Reikvam DH, Jevtovic D, Wiese L, Smidt J, Smiatacz T, Hassoun G, Kuznetsova A, Clotet B, Lundgren J, Mocroft A, EuroSIDA study (2018)
    Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort
    AIDS, 32 (16), 2405-2416
    DOI 10.1097/QAD.0000000000001967, PubMed 30134296
11. Quist-Paulsen E, Aukrust P, Kran AB, Dunlop O, Ormaasen V, Stiksrud B, Midttun Ø, Ueland T, Ueland PM, Mollnes TE, Dyrhol-Riise AM (2018)
    High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections
    J Neuroinflammation, 15 (1), 327
    DOI 10.1186/s12974-018-1366-3, PubMed 30470234
12. Sane Schepisi M, Navarra A, Altet Gomez MN, Dudnyk A, Dyrhol-Riise AM, Esteban J, Giorgetti PF, Gualano G, Guglielmetti L, Heyckendorf J, Kaluzhenina A, Lange B, Lange C, Manika K, Miah J, Nanovic Z, Pontali E, Prego MR, Solovic I, Tiberi S, Palmieri F, Girardi E (2018)
    Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study
    Open Forum Infect Dis, 6 (1), ofy337
    DOI 10.1093/ofid/ofy337, PubMed 30697572
13. Schein YL, Madebo T, Andersen HE, Arnesen TM, Dyrhol-Riise AM, Tveiten H, White RA, Winje BA (2018)
    Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study
    BMC Infect Dis, 18 (1), 587
    DOI 10.1186/s12879-018-3468-z, PubMed 30453946
14. Tveiten H, Brantsæter AB, Mengshoel AT (2018)
    Non-tuberculous mycobacterial pulmonary infections
    Tidsskr Nor Laegeforen, 138 (19)
    DOI 10.4045/tidsskr.18.0077, PubMed 30497255
15. Ursin Rein P, Jacobsen D, Ormaasen V, Dunlop O (2018)
    Pneumococcal sepsis requiring mechanical ventilation: Cohort study in 38 patients with rapid progression to septic shock
    Acta Anaesthesiol Scand, 62 (10), 1428-1435
    DOI 10.1111/aas.13236, PubMed 30132782
16. Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, Blix HS, Brantsæter AB, Holter EK, Handal N, Simonsen GS, Afset JE, Bakken Kran AM (2018)
    Stratification by interferon-γ release assay level predicts risk of incident TB
    Thorax, 73 (7), 652-661
    DOI 10.1136/thoraxjnl-2017-211147, PubMed 29622693

Publications 2017

1. Brekke K, Sommerfelt M, Ökvist M, Dyrhol-Riise AM, Kvale D (2017)
   The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
   BMC Infect Dis, 17 (1), 228
   DOI 10.1186/s12879-017-2316-x, PubMed 28340570
2. Chellappa S, Hugenschmidt H, Hagness M, Subramani S, Melum E, Line PD, Labori KJ, Wiedswang G, Taskén K, Aandahl EM (2017)
   CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer
   J Immunol, 198 (4), 1729-1739
   DOI 10.4049/jimmunol.1600061, PubMed 28053236
3. Dukic AR, Haugen LH, Pidoux G, Leithe E, Bakke O, Taskén K (2017)
   A protein kinase A-ezrin complex regulates connexin 43 gap junction communication in liver epithelial cells
   Cell Signal, 32, 1-11
   DOI 10.1016/j.cellsig.2017.01.008, PubMed 28077322
4. Feruglio SL, Kvale D, Dyrhol-Riise AM (2017)
   T Cell Responses and Regulation and the Impact of In Vitro IL-10 and TGF-β Modulation During Treatment of Active Tuberculosis
   Scand J Immunol, 85 (2), 138-146
   DOI 10.1111/sji.12511, PubMed 27862137
5. Gjøen JE, Jenum S, Sivakumaran D, Mukherjee A, Macaden R, Kabra SK, Lodha R, Ottenhoff THM, Haks MC, Doherty TM, Ritz C, Grewal HMS (2017)
   Novel transcriptional signatures for sputum-independent diagnostics of tuberculosis in children
   Sci Rep, 7 (1), 5839
   DOI 10.1038/s41598-017-05057-x, PubMed 28724962
6. Manner IW, Waldum-Grevbo B, Witczak BN, Bækken M, Øktedalen O, Os I, Schwartz T, Sjaastad I (2017)
   Immune markers, diurnal blood pressure profile and cardiac function in virologically suppressed HIV-infected patients
   Blood Press, 26 (6), 332-340
   DOI 10.1080/08037051.2017.1346459, PubMed 28675304
7. Musingwini TV, Zhou DT, Mhandire D, Duri K, Gomo E, Oktedalen O, Chimukangara B, Shamu T, Shawarira-Bote S, Dandara C, Stray-Pedersen B (2017)
   Use of Proviral DNA to Investigate Virus Resistance Mutations in HIV-infected Zimbabweans
   Open Microbiol J, 11, 45-52
   DOI 10.2174/1874285801711010045, PubMed 28553415
8. Muswe R, Oktedalen O, Zhou DT, Zinyando E, Shawarira-Bote S, Stray-Pedersen B, Siziba A, Gomo ZAR (2017)
   Inflammatory Markers and Plasma Lipids in HIV Patients: A Correlation Analysis Study
   Open Biochem J, 11, 105-118
   DOI 10.2174/1874091X01711010105, PubMed 29387269
9. Prebensen C, Trøseid M, Ueland T, Dahm A, Sandset PM, Aaberge I, Waalen K, Dyrhol-Riise AM, Taskén K, Kvale D (2017)
   Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
   PLoS One, 12 (5), e0176527
   DOI 10.1371/journal.pone.0176527, PubMed 28464042
10. van Santen DK, van der Helm JJ, Del Amo J, Meyer L, D'Arminio Monforte A, Price M, Béguelin CA, Zangerle R, Sannes M, Porter K, Geskus RB, Prins M, CASCADE Collaboration in EuroCoord (2017)
    Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990-2014
    J Hepatol, 67 (2), 255-262
    DOI 10.1016/j.jhep.2017.03.038, PubMed 28412290

Publications 2016

1. Bains SJ, Mahic M, Myklebust TÅ, Småstuen MC, Yaqub S, Dørum LM, Bjørnbeth BA, Møller B, Brudvik KW, Taskén K (2016)
   Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study
   J Clin Oncol, 34 (21), 2501-8
   DOI 10.1200/JCO.2015.65.3519, PubMed 27247217
2. Bates M, Brantsaeter AB (2016)
   Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen
   J Virus Erad, 2 (3), 136-42
   PubMed 27482452
3. Dukic AR, McClymont DW, Taskén K (2016)
   A Cell-Based High-Throughput Assay for Gap Junction Communication Suitable for Assessing Connexin 43-Ezrin Interaction Disruptors Using IncuCyte ZOOM
   SLAS Discov, 22 (1), 77-85
   DOI 10.1177/1087057116669120, PubMed 27628689
4. Jensenius M, Winje BA, Blomberg B, Mengshoel AT, Lippe Bv, Hannula R, Bruun JN, Knudsen PK, Rønning JO, Heldal E, Dyrhol-Riise AM (2016)
   Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014
   Int J Tuberc Lung Dis, 20 (6), 786-92
   DOI 10.5588/ijtld.15.0895, PubMed 27155182
5. Jenum S, Bakken R, Dhanasekaran S, Mukherjee A, Lodha R, Singh S, Singh V, Haks MC, Ottenhoff TH, Kabra SK, Doherty TM, Ritz C, Grewal HM (2016)
   BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome
   Sci Rep, 6, 38841
   DOI 10.1038/srep38841, PubMed 27941850
6. Liu LL, Landskron J, Ask EH, Enqvist M, Sohlberg E, Traherne JA, Hammer Q, Goodridge JP, Larsson S, Jayaraman J, Oei VYS, Schaffer M, Taskén K, Ljunggren HG, Romagnani C, Trowsdale J, Malmberg KJ, Béziat V (2016)
   Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans
   Cell Rep, 15 (5), 1088-1099
   DOI 10.1016/j.celrep.2016.04.005, PubMed 27117418
7. Midgard H, Bjøro B, Mæland A, Konopski Z, Kileng H, Damås JK, Paulsen J, Heggelund L, Sandvei PK, Ringstad JO, Karlsen LN, Stene-Johansen K, Pettersson JH, Dorenberg DH, Dalgard O (2016)
   Hepatitis C reinfection after sustained virological response
   J Hepatol, 64 (5), 1020-1026
   DOI 10.1016/j.jhep.2016.01.001, PubMed 26780289
8. Moltu K, Henjum K, Oberprieler NG, Bjørnbeth BA, Taskén K (2016)
   Proximal signaling responses in peripheral T cells from colorectal cancer patients are affected by high concentrations of circulating prostaglandin E₂
   Hum Immunol, 78 (2), 129-137
   DOI 10.1016/j.humimm.2016.10.007, PubMed 27769746
9. Nielsen HG, Øktedalen O, Opstad PK, Lyberg T (2016)
   Plasma Cytokine Profiles in Long-Term Strenuous Exercise
   J Sports Med (Hindawi Publ Corp), 2016, 7186137
   DOI 10.1155/2016/7186137, PubMed 27239554
10. Prebensen C, Lind A, Dyrhol-Riise AM, Kvale D (2016)
    Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy
    PLoS One, 11 (4), e0153849
    DOI 10.1371/journal.pone.0153849, PubMed 27128502
11. Stiksrud B, Lorvik KB, Kvale D, Mollnes TE, Ueland PM, Trøseid M, Taskén K, Dyrhol-Riise AM (2016)
    Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts
    J Acquir Immune Defic Syndr, 73 (2), 138-48
    DOI 10.1097/QAI.0000000000001080, PubMed 27632144
12. Tonby K, Wergeland I, Lieske NV, Kvale D, Tasken K, Dyrhol-Riise AM (2016)
    The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
    BMC Infect Dis, 16 (1), 599
    DOI 10.1186/s12879-016-1938-8, PubMed 27776487
13. Uyeki TM, Mehta AK, Davey RT, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, Evans L, Hewlett AL, Brantsaeter AB, Ippolito G, Rapp C, Hoepelman AI, Gutman J, Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and Europe (2016)
    Clinical Management of Ebola Virus Disease in the United States and Europe
    N Engl J Med, 374 (7), 636-46
    DOI 10.1056/NEJMoa1504874, PubMed 26886522
14. Wehbi VL, Taskén K (2016)
    Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units
    Front Immunol, 7, 222
    DOI 10.3389/fimmu.2016.00222, PubMed 27375620
15. Wergeland I, Assmus J, Dyrhol-Riise AM (2016)
    Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls
    PLoS One, 11 (9), e0163848
    DOI 10.1371/journal.pone.0163848, PubMed 27685462
16. Waagsbø B, Svardal A, Ueland T, Landrø L, Øktedalen O, Berge RK, Flo TH, Aukrust P, Damås JK (2016)
    Low levels of short- and medium-chain acylcarnitines in HIV-infected patients
    Eur J Clin Invest, 46 (5), 408-17
    DOI 10.1111/eci.12609, PubMed 26913383
17. Zhou DT, Nehumba D, Oktedalen O, Marange P, Kodogo V, Gomo ZA, Esterhuizen TM, Stray-Pedersen B (2016)
    Changes in Lipid Profiles of HIV(+) Adults over Nine Months at a Harare HIV Clinic: A Longitudinal Study
    Biochem Res Int, 2016, 3204818
    DOI 10.1155/2016/3204818, PubMed 27051532

Publications 2015

1. Chellappa S, Hugenschmidt H, Hagness M, Line PD, Labori KJ, Wiedswang G, Taskén K, Aandahl EM (2015)
   Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer
   Oncoimmunology, 5 (4), e1102828
   DOI 10.1080/2162402X.2015.1102828, PubMed 27141387
2. Chellappa S, Lieske NV, Hagness M, Line PD, Taskén K, Aandahl EM (2015)
   Human regulatory T cells control TCR signaling and susceptibility to suppression in CD4+ T cells
   J Leukoc Biol, 100 (1), 5-16
   DOI 10.1189/jlb.2HI0815-334R, PubMed 26715685
3. Feruglio SL, Tonby K, Kvale D, Dyrhol-Riise AM (2015)
   Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
   Clin Exp Immunol, 179 (3), 454-65
   DOI 10.1111/cei.12468, PubMed 25313008
4. Gerbaud P, Taskén K, Pidoux G (2015)
   Spatiotemporal regulation of cAMP signaling controls the human trophoblast fusion
   Front Pharmacol, 6, 202
   DOI 10.3389/fphar.2015.00202, PubMed 26441659
5. Gaardbo JC, Trøsied M, Stiksrud B, Midttun Ø, Ueland PM, Ullum H, Nielsen SD (2015)
   Increased Tryptophan Catabolism Is Associated With Increased Frequency of CD161+Tc17/MAIT Cells and Lower CD4+ T-Cell Count in HIV-1 Infected Patients on cART After 2 Years of Follow-Up
   J Acquir Immune Defic Syndr, 70 (3), 228-35
   DOI 10.1097/QAI.0000000000000758, PubMed 26470032
6. Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M et al. (2015)
   Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
   Clin Infect Dis, 62 (5), 655-663
   DOI 10.1093/cid/civ963, PubMed 26620652
7. Haabeth OA, Lorvik KB, Yagita H, Bogen B, Corthay A (2015)
   Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
   Oncoimmunology, 5 (1), e1039763
   DOI 10.1080/2162402X.2015.1039763, PubMed 26942052
8. Lieske NV, Tonby K, Kvale D, Dyrhol-Riise AM, Tasken K (2015)
   Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
   PLoS One, 10 (11), e0141903
   DOI 10.1371/journal.pone.0141903, PubMed 26544592
9. Parente-Ribes A, Skånland SS, Bürgler S, Os A, Wang D, Bogen B, Tjønnfjord GE, Taskén K, Munthe LA (2015)
   Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells
   Haematologica, 101 (2), e59-62
   DOI 10.3324/haematol.2015.135590, PubMed 26589914
10. Pidoux G, Taskén K (2015)
    Anchored PKA as a gatekeeper for gap junctions
    Commun Integr Biol, 8 (4), e1057361
    DOI 10.1080/19420889.2015.1057361, PubMed 26478781
11. Prebensen C, Ueland T, Michelsen AE, Lind A, Pettersen FO, Mollnes TE, Aukrust P, Dyrhol-Riise AM, Kvale D (2015)
    High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection
    J Acquir Immune Defic Syndr, 69 (4), 395-402
    DOI 10.1097/QAI.0000000000000617, PubMed 26115437
12. Raslan Z, Magwenzi S, Aburima A, Taskén K, Naseem KM (2015)
    Targeting of type I protein kinase A to lipid rafts is required for platelet inhibition by the 3',5'-cyclic adenosine monophosphate-signaling pathway
    J Thromb Haemost, 13 (9), 1721-34
    DOI 10.1111/jth.13042, PubMed 26176741
13. Riise AMD (2015)
    Our Voices HIV: 30 years in Norway
    Tidsskr. Nor. Laegeforen., 135 (19), 1769
14. Santegoets SJ, Dijkgraaf EM, Battaglia A, Beckhove P, Britten CM, Gallimore A, Godkin A, Gouttefangeas C, de Gruijl TD, Koenen HJ, Scheffold A, Shevach EM, Staats J, Taskén K, Whiteside TL, Kroep JR, Welters MJ, van der Burg SH (2015)
    Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
    Cancer Immunol Immunother, 64 (10), 1271-86
    DOI 10.1007/s00262-015-1729-x, PubMed 26122357
15. Stiksrud B, Nowak P, Nwosu FC, Kvale D, Thalme A, Sonnerborg A, Ueland PM, Holm K, Birkeland SE, Dahm AE, Sandset PM, Rudi K, Hov JR, Dyrhol-Riise AM, Trøseid M (2015)
    Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
    J Acquir Immune Defic Syndr, 70 (4), 329-37
    DOI 10.1097/QAI.0000000000000784, PubMed 26258571
16. Tonby K, Ruhwald M, Kvale D, Dyrhol-Riise AM (2015)
    IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
    Sci Rep, 5, 9223
    DOI 10.1038/srep09223, PubMed 25783975
17. Wergeland I, Pullar N, Assmus J, Ueland T, Tonby K, Feruglio S, Kvale D, Damås JK, Aukrust P, Mollnes TE, Dyrhol-Riise AM (2015)
    IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy
    J Infect, 70 (4), 381-91
    DOI 10.1016/j.jinf.2014.12.019, PubMed 25597826

Publications 2014

1. Brekke K, Lind A, Holm-Hansen C, Haugen IL, Sørensen B, Sommerfelt M, Kvale D (2014)
   Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trial
   PLoS One, 9 (11), e112556
   DOI 10.1371/journal.pone.0112556, PubMed 25398137
2. Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Mannsåker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F (2014)
   Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient
   Genome Biol, 15 (11), 490
   DOI 10.1186/s13059-014-0490-3, PubMed 25418686
3. Ellinger B, Silber J, Prashar A, Landskron J, Weber J, Rehermann S, Müller FJ, Smith S, Wrigley S, Taskén K, Gribbon P, Labes A, Imhoff JF (2014)
   A phenotypic screening approach to identify anticancer compounds derived from marine fungi
   Assay Drug Dev Technol, 12 (3), 162-75
   DOI 10.1089/adt.2013.564, PubMed 24735443
4. Halvorsen B, Smedbakken LM, Michelsen AE, Skjelland M, Bjerkeli V, Sagen EL, Taskén K, Bendz B, Gullestad L, Holm S, Biessen EA, Aukrust P (2014)
   Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13
   Atherosclerosis, 234 (2), 352-9
   DOI 10.1016/j.atherosclerosis.2014.03.021, PubMed 24732574
5. Hesstvedt L, Reikvam DH, Dunlop O (2014)
   Neurological melioidosis in Norway presenting with a cerebral abscess
   IDCases, 2 (1), 16-8
   DOI 10.1016/j.idcr.2014.11.001, PubMed 26793441
6. Landskron J, Helland Ø, Torgersen KM, Aandahl EM, Gjertsen BT, Bjørge L, Taskén K (2014)
   Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients
   Cancer Immunol Immunother, 64 (3), 337-47
   DOI 10.1007/s00262-014-1636-6, PubMed 25416072
7. Lind A, Brekke K, Pettersen FO, Mollnes TE, Trøseid M, Kvale D (2014)
   A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers
   PLoS One, 9 (1), e85604
   DOI 10.1371/journal.pone.0085604, PubMed 24416431
8. Maeland A (2014)
   Antiretroviral treatment initiation
   Lancet Infect Dis, 14 (12), 1175
   DOI 10.1016/S1473-3099(14)70947-8, PubMed 25455976
9. Manner IW, Baekken M, Oektedalen O, Kvale D, Nowak P, Nielsen SD, Os I, Trøseid M (2014)
   Plasma lipopolysaccharide and triglycerides are independently associated and both markers correlate with the development of metabolic syndrome in HIV infection
   J Acquir Immune Defic Syndr, 65 (4), e158-61
   DOI 10.1097/QAI.0000000000000055, PubMed 24577189
10. Mocroft A, Ryom L, Begovac J, Monforte AD, Vassilenko A, Gatell J, Florence E, Ormaasen V, Kirk O, Lundgren JD, EuroSIDA in EuroCOORD (2014)
    Deteriorating renal function and clinical outcomes in HIV-positive persons
    AIDS, 28 (5), 727-37
    DOI 10.1097/QAD.0000000000000134, PubMed 24983543
11. Olson AD, Guiguet M, Zangerle R, Gill J, Perez-Hoyos S, Lodi S, Ghosn J, Dorrucci M, Johnson A, Sannes M, Moreno S, Porter K, for CASCADE Collaboration in EuroCoord (2014)
    Evaluation of rapid progressors in HIV infection as an extreme phenotype
    J Acquir Immune Defic Syndr, 67 (1), 15-21
    DOI 10.1097/QAI.0000000000000240, PubMed 24872130
12. Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Trøseid M (2014)
    Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
    J Acquir Immune Defic Syndr, 67 (4), 370-4
    DOI 10.1097/QAI.0000000000000339, PubMed 25226210
13. Pettersen PS, Brox IK, Naman E, Bruun JN, Dyrhol-Riise AM, Trøseid M, Johannessen A (2014)
    Antiretroviral treatment failure predicts mortality in rural Tanzania
    Int J STD AIDS, 26 (9), 633-9
    DOI 10.1177/0956462414548460, PubMed 25122578
14. Pidoux G, Gerbaud P, Dompierre J, Lygren B, Solstad T, Evain-Brion D, Taskén K (2014)
    A PKA-ezrin-Cx43 signaling complex controls gap junction communication and thereby trophoblast cell fusion
    J Cell Sci, 127 (Pt 19), 4172-85
    DOI 10.1242/jcs.149609, PubMed 25052094
15. Pullar ND, Steinum H, Tonby K, Heggelund L, Leiva RA, Ofstad R, Bruun JN, Dyrhol-Riise AM (2014)
    Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway
    Int J Tuberc Lung Dis, 18 (2), 180-7
    DOI 10.5588/ijtld.13.0276, PubMed 24429310
16. Skånland SS, Moltu K, Berge T, Aandahl EM, Taskén K (2014)
    T-cell co-stimulation through the CD2 and CD28 co-receptors induces distinct signalling responses
    Biochem J, 460 (3), 399-410
    DOI 10.1042/BJ20140040, PubMed 24665965
17. Spurgeon BE, Aburima A, Oberprieler NG, Taskén K, Naseem KM (2014)
    Multiplexed phosphospecific flow cytometry enables large-scale signaling profiling and drug screening in blood platelets
    J Thromb Haemost, 12 (10), 1733-43
    DOI 10.1111/jth.12670, PubMed 25056834
18. Trøseid M, Ditlevsen S, Hvid T, Gerstoft J, Grøndahl T, Pedersen BK, Nielsen SD, Lindegaard B (2014)
    Reduced trunk fat and triglycerides after strength training are associated with reduced LPS levels in HIV-infected individuals
    J Acquir Immune Defic Syndr, 66 (2), e52-4
    DOI 10.1097/QAI.0000000000000132, PubMed 24608893
19. Trøseid M, Manner IW, Pedersen KK, Haissman JM, Kvale D, Nielsen SD (2014)
    Microbial translocation and cardiometabolic risk factors in HIV infection
    AIDS Res Hum Retroviruses, 30 (6), 514-22
    DOI 10.1089/aid.2013.0280, PubMed 24521167
20. Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, Aakhus S, Gude E, Bjørndal B, Halvorsen B, Karlsen TH, Aukrust P, Gullestad L, Berge RK, Yndestad A (2014)
    Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure
    J Intern Med, 277 (6), 717-26
    DOI 10.1111/joim.12328, PubMed 25382824
21. Wæhre T, Maagard A, Tappe D, Cadar D, Schmidt-Chanasit J (2014)
    Zika virus infection after travel to Tahiti, December 2013
    Emerg Infect Dis, 20 (8), 1412-4
    DOI 10.3201/eid2008.140302, PubMed 25062427

Publications 2013

1. Andersson LM, Vesterbacka J, Blaxhult A, Flamholc L, Nilsson S, Ormaasen V, Sönnerborg A, Gisslén M (2013)
   Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: an open-label randomized controlled trial
   Scand J Infect Dis, 45 (7), 543-51
   DOI 10.3109/00365548.2012.756985, PubMed 23294034
2. Cornez I, Joel M, Taskén K, Langmoen IA, Glover JC, Berge T (2013)
   EGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry
   J Neurooncol, 112 (1), 49-57
   DOI 10.1007/s11060-012-1035-9, PubMed 23299461
3. Drozd F, Skeie LG, Kraft P, Kvale D (2013)
   A web-based intervention trial for depressive symptoms and subjective well-being in patients with chronic HIV infection
   AIDS Care, 26 (9), 1080-9
   DOI 10.1080/09540121.2013.869541, PubMed 24359563
4. Feruglio SL, Trøseid M, Damås JK, Kvale D, Dyrhol-Riise AM (2013)
   Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses
   PLoS One, 8 (7), e69896
   DOI 10.1371/journal.pone.0069896, PubMed 23875007
5. Haugaard AK, Lund TT, Birch C, Rönsholt F, Trøseid M, Ullum H, Gerstoft J, Johansson PI, Nielsen SD, Ostrowski SR (2013)
   Discrepant coagulation profile in HIV infection: elevated D-dimer but impaired platelet aggregation and clot initiation
   AIDS, 27 (17), 2749-58
   DOI 10.1097/01.aids.0000432462.21723.ed, PubMed 23842126
6. Landskron J, Taskén K (2013)
   CD147 in regulatory T cells
   Cell Immunol, 282 (1), 17-20
   DOI 10.1016/j.cellimm.2013.04.008, PubMed 23665204
7. Lind A, Brekke K, Sommerfelt M, Holmberg JO, Aass HC, Baksaas I, Sørensen B, Dyrhol-Riise AM, Kvale D (2013)
   Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms
   Vaccine, 31 (41), 4611-8
   DOI 10.1016/j.vaccine.2013.07.037, PubMed 23906886
8. Lone AM, Taskén K (2013)
   Proinflammatory and immunoregulatory roles of eicosanoids in T cells
   Front Immunol, 4, 130
   DOI 10.3389/fimmu.2013.00130, PubMed 23760108
9. MacDonald E, Arnesen TM, Brantsaeter AB, Gerlyng P, Grepp M, Hansen BA, Jonsrud K, Lundgren B, Mellegard H, Moller-Stray J, Ronning K, Vestrheim DF, Vold L (2013)
   Outbreak of wound botulism in people who inject drugs, Norway, October to November 2013
   Eurosurveillance, 18 (45), 2-5
10. MacDonald E, Arnesen TM, Brantsaeter AB, Gerlyng P, Grepp M, Hansen BÅ, Jonsrud K, Lundgren B, Mellegård H, Møller-Stray J, Rønning K, Vestrheim DF, Vold L (2013)
    Outbreak of wound botulism in people who inject drugs, Norway, October to November 2013
    Euro Surveill, 18 (45), 20630
    DOI 10.2807/1560-7917.es2013.18.45.20630, PubMed 24229788
11. Madec Y, Boufassa F, Porter K, Prins M, Sabin C, d'Arminio Monforte A, Amornkul P, Bartmeyer B, Sannes M, Venet A, Lambotte O, Meyer L, CASCADE Collaboration in Eurocoord (2013)
    Natural history of HIV-control since seroconversion
    AIDS, 27 (15), 2451-60
    DOI 10.1097/01.aids.0000431945.72365.01, PubMed 23912979
12. Manner IW, Baekken M, Kvale D, Oektedalen O, Pedersen M, Nielsen SD, Nowak P, Os I, Trøseid M (2013)
    Markers of microbial translocation predict hypertension in HIV-infected individuals
    HIV Med, 14 (6), 354-61
    DOI 10.1111/hiv.12015, PubMed 23332095
13. Pedersen KK, Pedersen M, Trøseid M, Gaardbo JC, Lund TT, Thomsen C, Gerstoft J, Kvale D, Nielsen SD (2013)
    Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction
    J Acquir Immune Defic Syndr, 64 (5), 425-33
    DOI 10.1097/QAI.0b013e31829f919d, PubMed 23797689
14. Rogne M, Taskén K (2013)
    Cell signalling analyses in the functional genomics era
    N Biotechnol, 30 (3), 333-8
    DOI 10.1016/j.nbt.2013.01.003, PubMed 23369868
15. Singh M, Singh P, Vaira D, Torheim EA, Rahmouni S, Taskén K, Moutschen M (2013)
    The RIAD peptidomimetic inhibits HIV-1 replication in humanized NSG mice
    Eur J Clin Invest, 44 (2), 146-52
    DOI 10.1111/eci.12200, PubMed 24283208
16. Størvold GL, Landskron J, Strozynski M, Arntzen MØ, Koehler CJ, Kalland ME, Taskén K, Thiede B (2013)
    Quantitative profiling of tyrosine phosphorylation revealed changes in the activity of the T cell receptor signaling pathway upon cisplatin-induced apoptosis
    J Proteomics, 91, 344-57
    DOI 10.1016/j.jprot.2013.07.019, PubMed 23933134
17. Ushakova A, Pettersen FO, Mæland A, Lindqvist BH, Kvale D (2013)
    Bayesian estimation of HIV-1 dynamics in vivo
    Math Med Biol, 32 (1), 38-55
    DOI 10.1093/imammb/dqt018, PubMed 24078026
18. Vang T, Landskron J, Viken MK, Oberprieler N, Torgersen KM, Mustelin T, Tasken K, Tautz L, Rickert RC, Lie BA (2013)
    The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses
    Hum Immunol, 74 (5), 574-85
    DOI 10.1016/j.humimm.2012.12.017, PubMed 23333624

Publications 2012

1. Brantsæter AB (2012)
   [Malaria treatment--herbal therapy in new clothes]
   Tidsskr Nor Laegeforen, 132 (6), 614
   DOI 10.4045/tidsskr.12.0238, PubMed 22456126
2. Brantsæter AB, Johannessen A, Holberg-Petersen M, Sandvik L, Naman E, Kivuyo SL, Rollag H, Bruun JN, Kvale D (2012)
   Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania
   Int J Infect Dis, 16 (12), e879-85
   DOI 10.1016/j.ijid.2012.08.003, PubMed 23031419
3. Damås JK, Bækken M, Ueland T, Manner IW, Os I, Yndestad A, Flo TH, Øktedalen O, Aukrust P (2012)
   Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients
   J Acquir Immune Defic Syndr, 59 (2), e24-5
   DOI 10.1097/QAI.0b013e31823f35a7, PubMed 22245717
4. Damås JK, Øktedalen O, Ueland T, Landrø L, Barstad J, Müller F, Frøland SS, Flo TH, Aukrust P (2012)
   Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)
   Clin Exp Immunol, 167 (3), 492-8
   DOI 10.1111/j.1365-2249.2011.04524.x, PubMed 22288592
5. De Iaco G, Puro V, Fusco FM, Schilling S, Maltezou HC, Brouqui P, Gottschalk R, Bannister B, Brodt HR, Siikamaki H, Perronne C, Brantsæter AB, Fjellet AL, Ippolito G, European Network for Highly Infectious Diseases Working Group (2012)
   Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries
   Infect Control Hosp Epidemiol, 33 (10), 1008-16
   DOI 10.1086/667729, PubMed 22961020
6. Kalland ME, Solheim SA, Skånland SS, Taskén K, Berge T (2012)
   Modulation of proximal signaling in normal and transformed B cells by transmembrane adapter Cbp/PAG
   Exp Cell Res, 318 (14), 1611-9
   DOI 10.1016/j.yexcr.2012.05.014, PubMed 22659621
7. Lind A, Sommerfelt M, Holmberg JO, Baksaas I, Sørensen B, Kvale D (2012)
   Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years
   Scand J Infect Dis, 44 (8), 566-72
   DOI 10.3109/00365548.2011.653581, PubMed 22339485
8. Lodi S, Meyer L, Kelleher AD, Rosinska M, Ghosn J, Sannes M, Porter K (2012)
   Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion
   Arch Intern Med, 172 (16), 1252-5
   DOI 10.1001/archinternmed.2012.2719, PubMed 22826124
9. Manner IW, Trøseid M, Oektedalen O, Baekken M, Os I (2012)
   Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals
   J Clin Hypertens (Greenwich), 15 (2), 101-6
   DOI 10.1111/jch.12029, PubMed 23339727
10. Nowak P, Abdurahman S, Lindkvist A, Troseid M, Sönnerborg A (2012)
    Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection
    Int J Microbiol, 2012, 263836
    DOI 10.1155/2012/263836, PubMed 22719767
11. Nowak P, Nystrom J, Troseid M (2012)
    High levels of HMGB1 in plasma may be due to ex vivo cell necrosis
    Anticancer Res, 32 (9), 4067-9
    PubMed 22993362
12. Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J (2012)
    Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
    Arterioscler Thromb Vasc Biol, 33 (2), e47-55
    DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017
13. Quist-Paulsen E, Kran AM, Dunlop O, Wilson J, Ormaasen V (2012)
    Infectious encephalitis: a description of a Norwegian cohort
    Scand J Infect Dis, 45 (3), 179-85
    DOI 10.3109/00365548.2012.719634, PubMed 23113672
14. Rekić D, Röshammar D, Bergstrand M, Tarning J, Calcagno A, D'Avolio A, Ormaasen V, Vigan M, Barrail-Tran A, Ashton M, Gisslén M, Äbelö A (2012)
    External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients
    AAPS J, 15 (2), 308-15
    DOI 10.1208/s12248-012-9440-8, PubMed 23224752
15. Scott JD, Dessauer CW, Taskén K (2012)
    Creating order from chaos: cellular regulation by kinase anchoring
    Annu Rev Pharmacol Toxicol, 53, 187-210
    DOI 10.1146/annurev-pharmtox-011112-140204, PubMed 23043438
16. Trøseid M, Lind A, Nowak P, Barqasho B, Heger B, Lygren I, Pedersen KK, Kanda T, Funaoka H, Damås JK, Kvale D (2012)
    Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
    Innate Immun, 19 (3), 290-7
    DOI 10.1177/1753425912461042, PubMed 23070967
17. Wessman M, Westling K, Aho I, Quist-Paulsen E, Wæhre T, Rolfhamre L, Weis N, Katzenstein TL (2012)
    Major differences in assisted reproductive treatments offered to HIV-1 infected patients in the Nordic countries
    Scand J Infect Dis, 44 (5), 402-4
    DOI 10.3109/00365548.2011.649491, PubMed 22292615

Publications 2011

1. Berdal JE, Mollnes TE, Wæhre T, Olstad OK, Halvorsen B, Ueland T, Laake JH, Furuseth MT, Maagaard A, Kjekshus H, Aukrust P, Jonassen CM (2011)
   Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza
   J Infect, 63 (4), 308-16
   DOI 10.1016/j.jinf.2011.07.004, PubMed 21781987
2. Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
   Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
   BMC Infect Dis, 11, 75
   DOI 10.1186/1471-2334-11-75, PubMed 21435254
3. Brantsæter AB (2011)
   [Did vaccines and hygiene recommendations affect the pandemic?]
   Tidsskr Nor Laegeforen, 131 (7), 662
   DOI 10.4045/tidsskr.11.0318, PubMed 21494288
4. Corthay A, Lorvik KB, Bogen B (2011)
   Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?--Implications for cancer immunotherapy by adoptive T cell transfer
   Scand J Immunol, 73 (6), 527-30
   DOI 10.1111/j.1365-3083.2011.02558.x, PubMed 21388431
5. Hesstvedt L, Wilhelmsen M, Mengshoel AT, Dyrhol-Riise AM (2011)
   Two Norwegian patients with melioidosis presenting with bacteraemia and splenic and prostatic abscesses
   J Travel Med, 18 (6), 418-21
   DOI 10.1111/j.1708-8305.2011.00550.x, PubMed 22017720
6. Kivuyo SL, Johannessen A, Trøseid M, Kasubi MJ, Gundersen SG, Naman E, Mushi D, Ngowi BJ, Mfinanga GS, Bruun JN (2011)
   p24 antigen detection on dried blood spots is a feasible and reliable test for infant HIV infection in rural Tanzania
   Int J STD AIDS, 22 (12), 719-21
   DOI 10.1258/ijsa.2009.009382, PubMed 22174052
7. Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D (2011)
   Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection
   APMIS, 120 (3), 204-9
   DOI 10.1111/j.1600-0463.2011.02843.x, PubMed 22339677
8. Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
   An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
   J Virol, 85 (13), 6557-66
   DOI 10.1128/JVI.00073-11, PubMed 21490090
9. Rekić D, Clewe O, Röshammar D, Flamholc L, Sönnerborg A, Ormaasen V, Gisslén M, Abelö A, Ashton M (2011)
   Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy
   AAPS J, 13 (4), 598-605
   DOI 10.1208/s12248-011-9299-0, PubMed 21913053
10. Röshammar D, Simonsson US, Ekvall H, Flamholc L, Ormaasen V, Vesterbacka J, Wallmark E, Ashton M, Gisslén M (2011)
    Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients
    J Pharmacokinet Pharmacodyn, 38 (6), 727-42
    DOI 10.1007/s10928-011-9217-1, PubMed 21964996
11. Trøseid M (2011)
    [The fight against HIV--two scenarios]
    Tidsskr Nor Laegeforen, 131 (23), 2331
    DOI 10.4045/tidsskr.11.1213, PubMed 22139097
12. Trøseid M, Sönnerborg A, Nowak P (2011)
    High mobility group box protein-1 in HIV-1 infection
    Curr HIV Res, 9 (1), 6-10
    DOI 10.2174/157016211794582632, PubMed 21198433
13. van der Helm JJ, Prins M, del Amo J, Bucher HC, Chêne G, Dorrucci M, Gill J, Hamouda O, Sannes M, Porter K, Geskus RB, CASCADE Collaboration (2011)
    The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007
    AIDS, 25 (8), 1083-91
    DOI 10.1097/QAD.0b013e3283471cce, PubMed 21537114

Publications 2010

1. Baekken M, Manner I, Ueland T, Frøland SS, Os I, Aukrust P, Oktedalen O, Damås JK (2010)
   Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients
   J Acquir Immune Defic Syndr, 53 (3), 419-20
   DOI 10.1097/QAI.0b013e3181ba4101, PubMed 20190590
2. Bratholm C, Johannessen A, Naman E, Gundersen SG, Kivuyo SL, Holberg-Petersen M, Ormaasen V, Bruun JN (2010)
   Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital
   J Antimicrob Chemother, 65 (9), 1996-2000
   DOI 10.1093/jac/dkq234, PubMed 20576637
3. Edén A, Andersson LM, Andersson O, Flamholc L, Josephson F, Nilsson S, Ormaasen V, Svedhem V, Säll C, Sönnerborg A, Tunbäck P, Gisslén M (2010)
   Differential effects of efavirenz, lopinavir/r, and atazanavir/r on the initial viral decay rate in treatment naïve HIV-1-infected patients
   AIDS Res Hum Retroviruses, 26 (5), 533-40
   DOI 10.1089/aid.2009.0177, PubMed 20455766
4. Grydeland H, Walhovd KB, Westlye LT, Due-Tønnessen P, Ormaasen V, Sundseth Ø, Fjell AM (2010)
   Amnesia following herpes simplex encephalitis: diffusion-tensor imaging uncovers reduced integrity of normal-appearing white matter
   Radiology, 257 (3), 774-81
   DOI 10.1148/radiol.10100179, PubMed 20935078
5. Jenum PA, Flesland Ø, Blystad H, Vik IS, Hervig T, Maeland A, Saeter G (2010)
   [Syphilis and blood transfusion]
   Tidsskr Nor Laegeforen, 130 (8), 839-41
   DOI 10.4045/tidsskr.08.0188, PubMed 20418930
6. Johannessen A, Holberg-Petersen M, Lövgaarden G, Naman E, Ormaasen V, Matee MI, Gundersen SG, Bruun JN (2010)
   HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania
   Antivir Ther, 15 (7), 1003-9
   DOI 10.3851/IMP1660, PubMed 21041915
7. Kran AM, Jonassen TO, Sommerfelt MA, Løvgården G, Sørensen B, Kvale D (2010)
   Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides
   AIDS, 24 (17), 2609-18
   DOI 10.1097/QAD.0b013e32833e502b, PubMed 20935558
8. Pettersen FO, Taskén K, Kvale D (2010)
   Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection
   Clin Exp Immunol, 161 (2), 315-23
   DOI 10.1111/j.1365-2249.2010.04179.x, PubMed 20491784

Publications 2009

1. Brantsaeter AB (2009)
   [An underestimated throat bacteria]
   Tidsskr Nor Laegeforen, 129 (17), 1756
   DOI 10.4045/tidsskr.09.0788, PubMed 19756058
2. Corthay A, Lundin KU, Lorvik KB, Hofgaard PO, Bogen B (2009)
   Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells
   Cancer Res, 69 (14), 5901-7
   DOI 10.1158/0008-5472.CAN-08-4816, PubMed 19567679
3. Hauge SH, Dudman SG, Borgen K, Hungnes O, Brantsaeter A, Iversen B, Aavitsland P (2009)
   [Disease caused by the new influenza A(H1N1) virus]
   Tidsskr Nor Laegeforen, 129 (17), 1736-9
   DOI 10.4045/tidsskr.09.0748, PubMed 19756053
4. Josephson F, Andersson MC, Flamholc L, Gisslén M, Hagberg L, Ormaasen V, Sönnerborg A, Vesterbacka J, Böttiger Y (2009)
   The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
   Eur J Clin Pharmacol, 66 (4), 349-57
   DOI 10.1007/s00228-009-0763-z, PubMed 19967342
5. Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
   Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
   J Clin Microbiol, 47 (7), 2170-4
   DOI 10.1128/JCM.00519-09, PubMed 19420166
6. Maagaard A, Kvale D (2009)
   Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?
   J Antimicrob Chemother, 64 (5), 901-9
   DOI 10.1093/jac/dkp316, PubMed 19740910
7. Maagaard A, Kvale D (2009)
   Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity
   Scand J Infect Dis, 41 (11-12), 808-17
   DOI 10.3109/00365540903186181, PubMed 19922062
8. Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver DA, Albert J, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Coughlan S, Costagliola D, De Luca A, de Mendoza C, Derdelinckx I, Grossman Z, Hamouda O, Hoepelman I, Horban A, Korn K, Kücherer C, Leitner T et al. (2009)
   Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
   Retrovirology, 6, 49
   DOI 10.1186/1742-4690-6-49, PubMed 19457244
9. Sandanger Ø, Ryan L, Bohnhorst J, Iversen AC, Husebye H, Halaas Ø, Landrø L, Aukrust P, Frøland SS, Elson G, Visintin A, Øktedalen O, Damås JK, Sundan A, Golenbock D, Espevik T (2009)
   IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients
   J Immunol, 182 (1), 588-95
   DOI 10.4049/jimmunol.182.1.588, PubMed 19109192
10. Skeie L, Bugge H, Negaard A, Bergersen BM (2009)
    Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study
    HIV Med, 11 (3), 170-7
    DOI 10.1111/j.1468-1293.2009.00761.x, PubMed 19780861
11. Torheim EA, Ndhlovu LC, Pettersen FO, Larsen TL, Jha AR, Torgersen KM, Kvale D, Nixon DF, Taskén K, Aandahl EM (2009)
    Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population
    Eur J Immunol, 39 (5), 1280-7
    DOI 10.1002/eji.200839002, PubMed 19384871

Publications 2008

1. Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K, CASCADE Collaboration (2008)
   Changes in the risk of death after HIV seroconversion compared with mortality in the general population
   JAMA, 300 (1), 51-9
   DOI 10.1001/jama.300.1.51, PubMed 18594040
2. Bjark P, Ormaasen V, Skjelmerud T (2008)
   [Treatment of erythema migrans]
   Tidsskr Nor Laegeforen, 128 (24), 2844
   PubMed 19092956
3. Brantsaeter AB (2008)
   [Action against tuberculosis--all has its time]
   Tidsskr Nor Laegeforen, 128 (24), 2817
   PubMed 19092946
4. Holm M, Pettersen FO, Kvale D (2008)
   PD-1 predicts CD4 loss rate in chronic HIV-1 infection better than HIV RNA and CD38 but not in cryopreserved samples
   Curr HIV Res, 6 (1), 49-58
   PubMed 18288975
5. Josephson F, Bertilsson L, Böttiger Y, Flamholc L, Gisslén M, Ormaasen V, Sönnerborg A, Diczfalusy U (2008)
   CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels
   Eur J Clin Pharmacol, 64 (8), 775-81
   DOI 10.1007/s00228-008-0492-8, PubMed 18458892
6. Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D (2008)
   Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment
   J Infect Dis, 198 (10), 1474-81
   DOI 10.1086/592713, PubMed 18851688

Publications 2007

1. Brantsaeter AB, Holberg-Petersen M, Jeansson S, Goplen AK, Bruun JN (2007)
   CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection - a retrospective autopsy based study
   BMC Infect Dis, 7, 127
   DOI 10.1186/1471-2334-7-127, PubMed 17986346
2. Bugge H, Negaard A, Skeie L, Bergersen B (2007)
   Hyaluronic acid treatment of facial fat atrophy in HIV-positive patients
   HIV Med, 8 (8), 475-82
   DOI 10.1111/j.1468-1293.2007.00494.x, PubMed 17944679
3. Jensenius M, Berild D, Ormaasen V, Maehlen J, Lindegren G, Falk KI (2007)
   Fatal subarachnoidal haemorrhage in a Norwegian traveller with dengue virus infection
   Scand J Infect Dis, 39 (3), 272-4
   DOI 10.1080/00365540600891307, PubMed 17366065
4. Jensenius M, Maeland A, Brubakk O (2007)
   Extensive hookworm-related cutaneous larva migrans in Norwegian travellers to the tropics
   Travel Med Infect Dis, 6 (1-2), 45-7
   DOI 10.1016/j.tmaid.2007.09.043, PubMed 18342274
5. Maagaard A, Holberg-Petersen M, Torjesen PA, Bruun JN, Kvale D (2007)
   Insulin resistance is affected by increased levels of plasma lactate but not mitochondrial alterations in skeletal muscle in NRTI-exposed HIV-infected patients
   HIV Clin Trials, 8 (5), 345-53
   DOI 10.1310/hct0805-345, PubMed 17956836

Publications 2006

1. Bergersen BM (2006)
   Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy
   Drugs, 66 (15), 1971-87
   DOI 10.2165/00003495-200666150-00006, PubMed 17100407
2. Bergersen BM, Schumacher A, Sandvik L, Bruun JN, Birkeland K (2006)
   Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls
   Scand J Infect Dis, 38 (8), 682-9
   DOI 10.1080/00365540500361302, PubMed 16857615
3. Brantsaeter AB (2006)
   [Tularemia]
   Tidsskr Nor Laegeforen, 126 (8), 1034
   PubMed 16619059
4. Bruun JN, Skeie L, Maeland A, Dudman SG, Sannes M, Ormaasen V (2006)
   [HIV/AIDS--from lethal syndrome to chronic disease]
   Tidsskr Nor Laegeforen, 126 (23), 3121-4
   PubMed 17160119
5. Kran AM, Kvale D (2006)
   [Immunopathogenesis and therapeutic immunization in HIV-infection]
   Tidsskr Nor Laegeforen, 126 (23), 3112-6
   PubMed 17160117
6. Kran AM, Sørensen B, Sommerfelt MA, Nyhus J, Baksaas I, Kvale D (2006)
   Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells
   AIDS, 20 (4), 627-30
   DOI 10.1097/01.aids.0000210620.75707.ac, PubMed 16470131
7. Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K (2006)
   Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
   AIDS, 20 (6), 813-20
   DOI 10.1097/01.aids.0000218544.54586.f1, PubMed 16549964
8. Maagaard A, Holberg-Petersen M, Kollberg G, Oldfors A, Sandvik L, Bruun JN (2006)
   Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients
   Antivir Ther, 11 (5), 601-8
   PubMed 16964828
9. Maagaard A, Holberg-Petersen M, Kvittingen EA, Sandvik L, Bruun JN (2006)
   Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients
   HIV Med, 7 (1), 53-8
   DOI 10.1111/j.1468-1293.2005.00336.x, PubMed 16313293
10. Nygård K, Brantsaeter A, Feruglio S, Ravn J, Dotevall L, Hasle G, Myrvang B (2006)
    [Histoplasmosis among travellers to Central America]
    Tidsskr Nor Laegeforen, 126 (21), 2838-42
    PubMed 17086244
11. Skeie L, Maeland A (2006)
    Can efavirenz be taken in the morning?
    Scand J Infect Dis, 38 (11-12), 1089-91
    DOI 10.1080/00365540600794386, PubMed 17148083
12. van de Vijver DA, Wensing AM, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L et al. (2006)
    The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
    J Acquir Immune Defic Syndr, 41 (3), 352-60
    DOI 10.1097/01.qai.0000209899.05126.e4, PubMed 16540937

Publications 2005

1. Abrahamsen IW, Sømme S, Heldal D, Egeland T, Kvale D, Tjønnfjord GE (2005)
   Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease
   Haematologica, 90 (1), 86-93
   PubMed 15642674
2. Bergersen BM, Sandvik L, Ellingsen I, Bruun JN (2005)
   Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive
   HIV Med, 6 (4), 260-7
   DOI 10.1111/j.1468-1293.2005.00305.x, PubMed 16011531
3. Blystad H, Brantsaeter AB, Lovoll Ø (2005)
   Outbreak of community-acquired legionnaires disease in southeast Norway, May 2005
   Euro Surveill, 10 (5), E050526.1
   PubMed 16770016
4. Farah MG, Tverdal A, Steen TW, Heldal E, Brantsaeter AB, Bjune G (2005)
   Treatment outcome of new culture positive pulmonary tuberculosis in Norway
   BMC Public Health, 5, 14
   DOI 10.1186/1471-2458-5-14, PubMed 15698472
5. Kran AM, Sommerfelt MA, Sørensen B, Nyhus J, Baksaas I, Bruun JN, Kvale D (2005)
   Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization
   Vaccine, 23 (31), 4011-5
   DOI 10.1016/j.vaccine.2005.03.010, PubMed 15963359
6. Kvale D, Kran AM, Sommerfelt MA, Nyhus J, Baksaas I, Bruun JN, Sørensen B (2005)
   Divergent in vitro and in vivo correlates of HIV-specific T-cell responses during onset of HIV viraemia
   AIDS, 19 (6), 563-7
   DOI 10.1097/01.aids.0000163932.76531.c6, PubMed 15802974
7. Nygård K, Brantsaeter AB, Mehl R (2005)
   Disseminated and chronic Lyme borreliosis in Norway, 1995 - 2004
   Euro Surveill, 10 (10), 235-8
   PubMed 16282646
8. Nyhus J, Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D (2005)
   Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
   Vaccine, 24 (10), 1543-50
   DOI 10.1016/j.vaccine.2005.10.012, PubMed 16289707
9. Wensing AM, van de Vijver DA, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L et al. (2005)
   Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
   J Infect Dis, 192 (6), 958-66
   DOI 10.1086/432916, PubMed 16107947

Publications 2004

1. Cook CC, Brekke K (2004)
   Productivity preservation through hydraulic propped fractures in the Eldfisk North Sea chalk field
   SPE Reserv. Eval. Eng., 7 (2), 105-114
2. Kran AM, Sørensen B, Nyhus J, Sommerfelt MA, Baksaas I, Bruun JN, Kvale D (2004)
   HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
   AIDS, 18 (14), 1875-83
   DOI 10.1097/00002030-200409240-00003, PubMed 15353973
3. Lugada ES, Mermin J, Asjo B, Kaharuza F, Downing R, Langeland N, Ormaasen V, Bruun J, Awor AC, Ulvestad E (2004)
   Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway
   Scand J Immunol, 59 (2), 203-8
   DOI 10.1111/j.0300-9475.2004.01376.x, PubMed 14871298
4. Nilssen DE, Øktedalen O, Brandtzaeg P (2004)
   Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy
   Gut, 53 (4), 487-93
   DOI 10.1136/gut.2003.027854, PubMed 15016741

Publications 2003

1. Maeland A, Ronnestad I, Waagbo R (2003)
   Folate in eggs and developing larvae of Atlantic halibut, Hippoglossus hippoglossus L.
   Aquac. Nutr., 9 (3), 185-188

Publications 2002

1. Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker SA, Beral V, Coutinho R, Del Amo J, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, Lawson-Aye S, Boufassa F, Hamouda O, Fischer K, Pezzotti P, Rezza G, Touloumi G, Hatzakis A, Karafoulidou A, Katsarou O et al. (2002)
   Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks
   Int J Epidemiol, 31 (5), 951-8
   DOI 10.1093/ije/31.5.951, PubMed 12435766
2. Bjøro K, Bell H, Hellum KB, Skaug K, Raknerud N, Sandvei P, Døskeland B, Maeland A, Lund-Tønnesen S, Myrvang B (2002)
   Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study
   Scand J Gastroenterol, 37 (2), 226-32
   DOI 10.1080/003655202753416920, PubMed 11843062
3. Bruun JN, Maeland A (2002)
   [Mother-to-child transmission of HIV]
   Tidsskr Nor Laegeforen, 122 (11), 1143; author reply 1143
   PubMed 12043061
4. Dunlop O, Bjørklund R, Bruun JN, Evensen R, Goplen AK, Liestøl K, Sannes M, Maehlen J, Myrvang B (2002)
   Early psychomotor slowing predicts the development of HIV dementia and autopsy-verified HIV encephalitis
   Acta Neurol Scand, 105 (4), 270-5
   DOI 10.1034/j.1600-0404.2002.9o188.x, PubMed 12004769
5. Miller V, Phillips AN, Clotet B, Mocroft A, Ledergerber B, Kirk O, Ormaasen V, Gargalianos-Kakolyris P, Vella S, Lundgren JD (2002)
   Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts
   J Infect Dis, 186 (2), 189-97
   DOI 10.1086/341466, PubMed 12134254
6. Mørch K, Feruglio SL, Ormaasen V, Bruun JN (2002)
   [Severe falciparum malaria treated with exchange transfusion]
   Tidsskr Nor Laegeforen, 122 (10), 999-1001
   PubMed 12082710
7. Maagaard A, Oktedalen O (2002)
   Psoas abscess diagnosed at a Northern university hospital
   Scand J Infect Dis, 34 (11), 848-51
   DOI 10.1080/0036554021000026944, PubMed 12578159
8. Rollag H, Sagedal S, Kristiansen KI, Kvale D, Holter E, Degré M, Nordal KP (2002)
   Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
   Clin Microbiol Infect, 8 (7), 431-4
   DOI 10.1046/j.1469-0691.2002.00449.x, PubMed 12199854
9. Røttingen JA, Feruglio SL, Aasland OG, Fugelli P (2002)
   [Local and global environmental medicine--assessment by Norwegian physicians]
   Tidsskr Nor Laegeforen, 122 (13), 1285-9
   PubMed 12098923

Publications 2001

1. Oktedalen O, Solberg EE, Haugen AH, Opstad PK (2001)
   The influence of physical and mental training on plasma beta-endorphin level and pain perception after intensive physical exercise
   Stress Health, 17 (2), 121-127
2. Ormaasen V, Brantsaeter AB, Moen EW (2001)
   [Tick-borne encephalitis in Norway]
   Tidsskr Nor Laegeforen, 121 (7), 807-9
   PubMed 11301704
3. Ormaasen V, Maeland A (2001)
   [Tuberculosis among HIV-infected persons in Norway]
   Tidsskr Nor Laegeforen, 121 (29), 3425-30
   PubMed 11826791
4. Svendsen J, Ormaasen V, von der Lippe E, Jacobsen D (2001)
   [Two cases of pneumococcal pericarditis]
   Tidsskr Nor Laegeforen, 121 (15), 1801-3
   PubMed 11464685

Publications 2000

1. Bøyum A, Tennfjord VA, Gran C, Løvhaug D, Oktedalen O, Brandtzaeg P (2000)
   Bioactive cytidine deaminase, an inhibitor of granulocyte-macrophage colony-forming cells, is massively released in fulminant meningococcal sepsis
   J Infect Dis, 182 (6), 1784-7
   DOI 10.1086/317596, PubMed 11069255
2. Dyrhol-Riise AM, Brantsaeter AB, Dunlop O, Baklien K, Skar AG, Asjö B, Bruun JN, Røsok BI (2000)
   Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals
   Scand J Immunol, 51 (2), 195-201
   PubMed 10652164
3. Maeland A, Ronnestad I, Fyhn HJ, Berg L, Waagbo R (2000)
   Water-soluble vitamins in natural plankton (copepods) during two consecutive spring blooms compared to vitamins in Artemia franciscana nauplii and metanauplii
   Mar. Biol., 136 (5), 765-772
4. Olsen AI, Maeland A, Waagbo R, Olsen Y (2000)
   Effect of algal addition on stability of fatty acids and some water-soluble vitamins in juvenile Artemia franciscana
   Aquac. Nutr., 6 (4), 263-273
5. Sindre H, Haraldsen G, Beck S, Hestdal K, Kvale D, Brandtzaeg P, Degré M, Rollag H (2000)
   Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection
   Scand J Immunol, 51 (4), 354-60
   PubMed 10736107

Publications 1999

1. Bell H, Hellum K, Harthug S, Myrvang B, Ritland S, Maeland A, von der Lippe B, Bjøro K, Skaug K, Gutigard BG, Raknerud N, Simmonds P (1999)
   Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group
   Scand J Gastroenterol, 34 (2), 194-8
   PubMed 10192200
2. Maeland A, Rosenlund G, Stoss J, Waagbo R (1999)
   Weaning of Atlantic halibut Hippoglossus hippoglossus L. using formulated diets with various levels of ascorbic acid
   Aquac. Nutr., 5 (3), 211-219
3. Maeland A, Sandnes K (1999)
   Determination of biotin in low-temperature fish-meal processed from different species by means of a microbiological method using Lactobacillus plantarum as test organism
   J. Sci. Food Agric., 79 (10), 1298-1300
4. Mugnaini EN, Haaheim LL, Sannes M, Brinchmann JE (1999)
   In vivo expansion coincident with excessive in vitro cell death within the memory subset of CD8+ T cells in HIV type 1 infection
   AIDS Res Hum Retroviruses, 15 (3), 265-72
   DOI 10.1089/088922299311448, PubMed 10052757
5. Mugnaini EN, Syversen AM, Sannes M, Freng A, Brinchmann JE (1999)
   Normal CD4 T-cell receptor repertoire in tonsillar tissue despite perturbed repertoire in peripheral blood in HIV-1 infected individuals
   AIDS, 13 (18), 2507-13
   DOI 10.1097/00002030-199912240-00003, PubMed 10630519

Publications 1998

1. Brantsaeter AB, Hoel T, Kristianslund TI, Maeland A (1998)
   [Tularemia after tick bite in Vestfold]
   Tidsskr Nor Laegeforen, 118 (8), 1191-3
   PubMed 9567695
2. Jarvis LM, Bell H, Simmonds P, Hawkins A, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K (1998)
   The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group
   Scand J Gastroenterol, 33 (2), 195-200
   PubMed 9517532
3. Maeland A, Waagbo R (1998)
   Examination of the qualitative ability of some cold water marine teleosts to synthesise ascorbic acid
   Comp. Biochem. Physiol. A-Mol. Integr. Physiol., 121 (3), 249-255
4. Mugnaini EN, Spurkland A, Egeland T, Sannes M, Brinchmann JE (1998)
   Demonstration of identical expanded clones within both CD8+CD28+ and CD8+CD28- T cell subsets in HIV type 1-infected individuals
   Eur J Immunol, 28 (5), 1738-42
   DOI 10.1002/(SICI)1521-4141(199806)28:06<1745::AID-IMMU1745>3.0.CO;2-5, PubMed 9603481
5. Nilssen DE, Oktedalen O, Lygren I, Opstad PK, Brandtzaeg P (1998)
   Intestinal IgA- and IgM-producing cells are not decreased in marathon runners
   Int J Sports Med, 19 (6), 425-31
   DOI 10.1055/s-2007-971940, PubMed 9774211

Publications 1997

1. Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Gutigard BG, Skjaerven R, Prescott LE, Simmonds P (1997)
   Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group
   Scand J Infect Dis, 29 (1), 17-22
   DOI 10.3109/00365549709008658, PubMed 9112292
2. Jensenius M, Espinoza R, Hoel T, Oktedalen O, Heger B, Skar AG, Grinde B, Skaug K, Berild D (1997)
   [An outbreak of hepatitis A among intravenous drug addicts in Oslo 1995-96]
   Tidsskr Nor Laegeforen, 117 (7), 935-40
   PubMed 9103002
3. Jensenius M, Maeland A, Kvale D, Farstad IN, Vene S, Bruu AL (1997)
   [Q-fever imported into Norway]
   Tidsskr Nor Laegeforen, 117 (27), 3937-40
   PubMed 9441420
4. Jensenius M, Maeland A, Vene S (1997)
   [Endemic typhus imported to Norway]
   Tidsskr Nor Laegeforen, 117 (17), 2447-9
   PubMed 9265302
5. Maeland A (1997)
   [Screening of pregnant women for toxoplasma infection]
   Tidsskr Nor Laegeforen, 117 (8), 1184-5
   PubMed 9148496
6. Nordøy I, Krarup HB, Bell H, Christensen PB, Elgjo K, von der Lippe B, De Muckadell OS, Maeland A, Ring-Larsen H, Samdal HH, Simmonds P, Skaug K, Tage-Jensen U, Schrumpf E (1997)
   Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study
   Scand J Gastroenterol, 32 (12), 1256-60
   DOI 10.3109/00365529709028156, PubMed 9438325

Publications 1996

1. Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Prescott L, Simmonds P (1996)
   Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group
   Scand J Infect Dis, 28 (4), 357-9
   DOI 10.3109/00365549609037919, PubMed 8893398
2. Dunlop O, Rootwelt V, Sannes M, Goplen AK, Abdelnoor M, Skaug K, Baklien K, Skar A, Melby K, Myrvang B, Bruun JN (1996)
   Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxis
   Scand J Infect Dis, 28 (1), 71-3
   DOI 10.3109/00365549609027153, PubMed 9122637
3. Nilssen DE, Müller F, Oktedalen O, Frøland SS, Fausa O, Halstensen TS, Brandtzaeg P (1996)
   Intraepithelial gamma/delta T cells in duodenal mucosa are related to the immune state and survival time in AIDS
   J Virol, 70 (6), 3545-50
   PubMed 8648688
4. Schrumpf E, Bjøro K, Bell H, Harthug S, Hellum KB, Myrvang B, Maeland A, Ritland S (1996)
   [Treatment of hepatitis C]
   Tidsskr Nor Laegeforen, 116 (15), 1792-4
   PubMed 8693463

Publications 1995

1. BJORO K, KRARUP H, BELL H, CHRISTOPHERSEN P, EVENSEN S, FROLAND SS, LAURSEN A, VANDERLIPPE B, MAELAND A, RANEK L, RINGLARSEN H, SCHOU G, SCHRUMPF E, TYGSTRUP N (1995)
   2 DOSE REGIMENS OF RECOMBINANT INTERFERON-ALPHA-2B IN CHRONIC HEPATITIS-C VIRUS-INFECTION - BIOCHEMISTRY, HEPATITIS-C VIRUS RNA, AND LIVER HISTOLOGY AS RESPONSE INDICES
   Scand. J. Gastroenterol., 30 (11), 1119-1124
2. Bjøro K, Krarup H, Bell H, Christophersen P, Evensen S, Frøland SS, Laursen A, B vd Lippe B, Maeland A, Ranek L (1995)
   Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices
   Scand J Gastroenterol, 30 (11), 1119-24
   PubMed 8578174

Publications 1994

1. Brinchmann JE, Dobloug JH, Heger BH, Haaheim LL, Sannes M, Egeland T (1994)
   Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations
   J Infect Dis, 169 (4), 730-8
   DOI 10.1093/infdis/169.4.730, PubMed 7907640

Publications 1993

1. Sandven P, Bjørneklett A, Maeland A (1993)
   Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group
   Antimicrob Agents Chemother, 37 (11), 2443-8
   DOI 10.1128/aac.37.11.2443, PubMed 8285631

Publications 1992

1. Larsen J, Skaug K, Maeland A (1992)
   Second-generation anti-HCV tests predict infectivity
   Vox Sang, 63 (1), 39-42
   PubMed 1384236
2. LARSEN J, SKAUG K, MAELAND A (1992)
   2ND-GENERATION ANTI-HCV TESTS PREDICT INFECTIVITY
   Vox Sang., 63 (1), 39-42
3. NORRBY SR, GOTZSCHE PC, MELANDER H, ANDERSEN P, LAHDEVIRTA J, GUDMUNDSSON S, BRUUN JN, BERGLUND O, SKINHOJ P, GERSTOFT J, THYBO S, GIEMSING P, SOEBERG B, ISAGER H, MOLLER A, KROON S, MAELAND A, DOBLOUG JH, FROLAND S, SCHREINER A, HELLUM KB, LINDBACK S, JACOBSSON B, PEHRSON PO, SKOLDENBERG B et al. (1992)
   DOUBLE-BLIND DOSE-RESPONSE STUDY OF ZIDOVUDINE IN AIDS AND ADVANCED HIV-INFECTION
   Br. Med. J., 304 (6818), 13-17

Publications 1991

1. Brandtzaeg P, Waage A, Mollnes TE, Oktedalen O, Kierulf P (1991)
   Severe human septic shock involves more than tumor necrosis factor
   Prog Clin Biol Res, 367, 25-42
   PubMed 1924430
2. BRANDTZAEG P, WAAGE A, MOLLNES TE, OKTEDALEN O, KIERULF P (1991)
   SEVERE HUMAN SEPTIC SHOCK INVOLVES MORE THAN TUMOR-NECROSIS-FACTOR
   Prog.Clin.Biol.Res., 367, 25-42
3. Larsen J, Hetland G, Skaug K, Maeland A (1991)
   [Viral hepatitis and blood transfusion]
   Tidsskr Nor Laegeforen, 111 (7), 825-8
   PubMed 1850559
4. Larsen J, Skaug K, Maeland A, Hetland G, Stoervold G (1991)
   Infective, chronic carriers of hepatitis C virus among blood donors with no history of clinical hepatitis
   Transfus Med, 1 (1), 13-6
   PubMed 9259821
5. MAELAND A (1991)
   SYSTEMIC CANDIDA INFECTIONS
   Curr. Med. Res. Opin., 12 1, 26-31
6. OKTEDALEN O, NYGARD K, OSNES M (1991)
   TREATING A PATIENT WITH PANCREATIC ASCITES BY AN INTRAVENOUS-INFUSION OF A SOMATOSTATIN ANALOG - REPLY
   Gastroenterology, 100 (6), 1785

Publications 1989

1. MAELAND A, SKAUG K, STORVOLD G, KITTELSEN P (1989)
   REACTIVATION OF HEPATITIS-B
   Lancet, 1 (8646), 1083

Publications 1988

1. Maeland A (1988)
   [Acute HIV disease]
   Tidsskr Nor Laegeforen, 108 (22), 1619-20, 1654
   PubMed 3413748